Saga Y, Chiang C, Wakamatsu A
Neuropsychopharmacol Rep. 2023; 44(1):221-226.
PMID: 37884014
PMC: 10932779.
DOI: 10.1002/npr2.12385.
Caballero J, Xu J, Hall D, Chen X, Young H
Ment Health Clin. 2023; 13(4):183-189.
PMID: 37860586
PMC: 10583257.
DOI: 10.9740/mhc.2023.08.183.
Mostert-Kerckhoffs M, Willems A, Tenback D, Koning J, Van Harten P, Staal W
J Autism Dev Disord. 2019; 50(2):415-428.
PMID: 31673907
DOI: 10.1007/s10803-019-04171-1.
Balint B, Killaspy H, Marston L, Barnes T, Latorre A, Joyce E
BJPsych Open. 2018; 4(5):404-410.
PMID: 30294450
PMC: 6171333.
DOI: 10.1192/bjo.2018.55.
Park C, Lee H, Oh D, Kang J, Han C, Kim D
Drug Des Devel Ther. 2018; 12:711-719.
PMID: 29670329
PMC: 5896679.
DOI: 10.2147/DDDT.S151437.
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
Alabed S, Latifeh Y, Mohammad H, Bergman H
Cochrane Database Syst Rev. 2018; 4:CD000203.
PMID: 29663328
PMC: 6513215.
DOI: 10.1002/14651858.CD000203.pub4.
Cholinergic medication for antipsychotic-induced tardive dyskinesia.
Tammenmaa-Aho I, Asher R, Soares-Weiser K, Bergman H
Cochrane Database Syst Rev. 2018; 3:CD000207.
PMID: 29553158
PMC: 6494194.
DOI: 10.1002/14651858.CD000207.pub2.
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.
Soares-Weiser K, Rathbone J, Ogawa Y, Shinohara K, Bergman H
Cochrane Database Syst Rev. 2018; 3:CD000208.
PMID: 29552749
PMC: 6494382.
DOI: 10.1002/14651858.CD000208.pub2.
Benzodiazepines for antipsychotic-induced tardive dyskinesia.
Bergman H, Bhoopathi P, Soares-Weiser K
Cochrane Database Syst Rev. 2018; 1:CD000205.
PMID: 29352477
PMC: 6491128.
DOI: 10.1002/14651858.CD000205.pub3.
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
El-Sayeh H, Rathbone J, Soares-Weiser K, Bergman H
Cochrane Database Syst Rev. 2018; 1:CD000458.
PMID: 29342497
PMC: 6491120.
DOI: 10.1002/14651858.CD000458.pub3.
Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
Bergman H, Soares-Weiser K
Cochrane Database Syst Rev. 2018; 1:CD000204.
PMID: 29341071
PMC: 6491293.
DOI: 10.1002/14651858.CD000204.pub2.
Tardive Dyskinesia, Oral Parafunction, and Implant-Supported Rehabilitation.
Lumetti S, Ghiacci G, Macaluso G, Amore M, Galli C, Calciolari E
Case Rep Dent. 2017; 2016:7167452.
PMID: 28050290
PMC: 5168480.
DOI: 10.1155/2016/7167452.
Heavy Alcohol Drinking Associated Akathisia and Management with Quetiapine XR in Alcohol Dependent Patients.
Kurlawala Z, Vatsalya V
J Addict. 2016; 2016:6028971.
PMID: 27847671
PMC: 5099459.
DOI: 10.1155/2016/6028971.
Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia.
Wang D, Cao B, Xu M, Liu Y, Yan L, Liu R
Medicine (Baltimore). 2015; 94(36):e1507.
PMID: 26356721
PMC: 4616632.
DOI: 10.1097/MD.0000000000001507.
Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
Fedorenko O, Loonen A, Lang F, Toshchakova V, Boyarko E, Semke A
Int J Neuropsychopharmacol. 2014; 18(6).
PMID: 25548108
PMC: 4438543.
DOI: 10.1093/ijnp/pyu098.
Second-generation antipsychotics and extrapyramidal adverse effects.
Divac N, Prostran M, Jakovcevski I, Cerovac N
Biomed Res Int. 2014; 2014:656370.
PMID: 24995318
PMC: 4065707.
DOI: 10.1155/2014/656370.
Tardive and spontaneous dyskinesia incidence in the general population.
Merrill R, Lyon J, Matiaco P
BMC Psychiatry. 2013; 13:152.
PMID: 23714238
PMC: 3681708.
DOI: 10.1186/1471-244X-13-152.
Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.
Koning J, Vehof J, Burger H, Wilffert B, Al Hadithy A, Alizadeh B
Psychopharmacology (Berl). 2011; 219(3):727-36.
PMID: 21750899
DOI: 10.1007/s00213-011-2394-1.
Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia.
Zhang X, Chen D, Qi L, Wang F, Xiu M, Chen S
Psychopharmacology (Berl). 2009; 205(4):647-54.
PMID: 19529921
DOI: 10.1007/s00213-009-1590-8.
Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis.
Koning J, Tenback D, van Os J, Aleman A, Kahn R, van Harten P
Schizophr Bull. 2008; 36(4):723-31.
PMID: 18990712
PMC: 2894597.
DOI: 10.1093/schbul/sbn146.